Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1Phase 2 1Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Colorectal Neoplasms 56Rectal Neoplasms 30Colonic Neoplasms 29Pancreatic Neoplasms 28Neoplasms 20Neoplasm Metastasis 18Stomach Neoplasms 17Carcinoma, Non-Small-Cell Lung 14Unspecified Adult Solid Tumor, Protocol Specific 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Leukemia, Myeloid, Acute 8Esophageal Neoplasms 8Ovarian Neoplasms 7Lymphoma, Non-Hodgkin 7Lymphoma 7Adenocarcinoma 7Myelodysplastic Syndromes 6Lung Neoplasms 6Gallbladder Neoplasms 6Breast Neoplasms 6Sarcoma 5Osteosarcoma 5Liver Neoplasms 5Leukemia, Lymphocytic, Chronic, B-Cell 5Hodgkin Disease 5Carcinoma, Renal Cell 5Carcinoma, Hepatocellular 5Bile Duct Neoplasms 5Triple Negative Breast Neoplasms 4Solid Tumor 4

Interventions

Zidovudine 6tecogalan 4Vincristine 4Interferon alpha-2 4Doxorubicin 4Bleomycin 4sargramostim 3pomalidomide 2interferon alfa-n1 2liposomal doxorubicin 1Zalcitabine 1Tumor Necrosis Factor-alpha 1Sorafenib 1Pentoxifylline 1O-(Chloroacetylcarbamoyl)fumagillol 1Nivolumab 1Muromonab-CD3 1Methotrexate 1Leucovorin 1Isotretinoin 1Interleukin-4 1Interleukin-2 1Interferon beta-1b 1Etoposide 1Didanosine 1Dexamethasone 1Cytarabine 1Cyclophosphamide 1Cidofovir 14,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Acquired Immunodeficiency Syndrome × Leucovorin × Clear all
NCT00000689 2021-11-02

Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in AIDS-Associated Large Cell, Immunoblastic, and Small Non-cleaved Lymphoma

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 1 Completed
18 enrolled
Lymphoid

Acquired Immunodeficiency Syndrome, Lymphoma, Non-Hodgkin, Nervous System Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡